Andrew Sinclair

Latest from Andrew Sinclair

Evolution and Uptake of Bioprocess Economic Modelling
Sponsored Content
Evolution and Uptake of Bioprocess Economic ModellingEvolution and Uptake of Bioprocess Economic Modelling
byAndrew Sinclair, David Pollardand 2 more
Aug 19, 2022
Rapid Deployment of Manufacturing Options: An Analysis of Risks and Benefits
Facility Design/Engineering
Rapid Deployment of Manufacturing Options: An Analysis of Risks and BenefitsRapid Deployment of Manufacturing Options: An Analysis of Risks and Benefits
byAndrew Sinclair, Sa'ad Ojelliand 4 more
May 21, 2021

All from Andrew Sinclair

Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 2
Cell Therapies
Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 2
Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 2
Apr 20, 2018
+1
byAdriana G. Lopes, Andrew Sinclairand 1 more
Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 1
Cell Therapies
Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 1
Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 1
Mar 27, 2018
+1
byAdriana G. Lopes, Andrew Sinclairand 1 more
Standardized Economic Cost Modeling for Next-Generation MAb Production
Economics
Standardized Economic Cost Modeling for Next-Generation MAb Production
Standardized Economic Cost Modeling for Next-Generation MAb Production
Sep 15, 2016
+3
byDavid Pollard, Mark Browerand 3 more
A Sustainable, Single-Use Facility for Monoclonal Antibody Production logo in a gray background | A Sustainable, Single-Use Facility for Monoclonal Antibody Production
MAb
A Sustainable, Single-Use Facility for Monoclonal Antibody Production
A Sustainable, Single-Use Facility for Monoclonal Antibody Production
Dec 1, 2013
+4
byOlivier Cochet, PhD, Jean-Claude Corbiereand 4 more
Inactivated Poliovirus Vaccine Made in Modular Facilities with Single-Use Technology logo in a gray background | Inactivated Poliovirus Vaccine Made in Modular Facilities with Single-Use Technology
Single Use
Inactivated Poliovirus Vaccine Made in Modular Facilities with Single-Use Technology
Inactivated Poliovirus Vaccine Made in Modular Facilities with Single-Use Technology
Oct 1, 2013
byAndrew Sinclair, Nigel Titchener-Hooker
A Framework for Process Knowledge Management logo in a gray background | A Framework for Process Knowledge Management
Information Technology
A Framework for Process Knowledge Management
A Framework for Process Knowledge Management
Dec 1, 2012
+1
byAndrew Sinclair, Miriam Mongeand 1 more
Monoclonal Antibody Manufacturing logo in a gray background | Monoclonal Antibody Manufacturing
MAb
Monoclonal Antibody Manufacturing
Monoclonal Antibody Manufacturing
Oct 1, 2011
byAndrew Sinclair, Miriam Monge
Modeling Bioprocess Cost logo in a gray background | Modeling Bioprocess Cost
Expression Platforms
Modeling Bioprocess Cost
Modeling Bioprocess Cost
Nov 1, 2010
+3
byJanice AC Lim, Anant Patkarand 3 more
Influence of Process Development Decisions on Manufacturing Costs logo in a gray background | Influence of Process Development Decisions on Manufacturing Costs
Economics
Influence of Process Development Decisions on Manufacturing Costs
Influence of Process Development Decisions on Manufacturing Costs
Sep 1, 2010
byAndrew Sinclair, Miriam Monge
Measuring Manufacturing Cost and Its Impact on Organizations logo in a gray background | Measuring Manufacturing Cost and Its Impact on Organizations
Assays
Measuring Manufacturing Cost and Its Impact on Organizations
Measuring Manufacturing Cost and Its Impact on Organizations
Jun 1, 2010
byAndrew Sinclair, Miriam Monge
How Geography Affects the Cost of Biomanufacturing logo in a gray background | How Geography Affects the Cost of Biomanufacturing
Facility Design/Engineering
How Geography Affects the Cost of Biomanufacturing
How Geography Affects the Cost of Biomanufacturing
Jun 1, 2010
byAndrew Sinclair
Delivering Affordable Biologics from Gene to Vial logo in a gray background | Delivering Affordable Biologics from Gene to Vial
Economics
Delivering Affordable Biologics from Gene to Vial
Delivering Affordable Biologics from Gene to Vial
Mar 1, 2010
byAndrew Sinclair, Miriam Monge

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process
Register Now: Demonstrating a Modular Selectivity With a Weak AEX-HIC Resin for Achieving High mAb Purity and Recovery in a Downstream Process
Insider News
See all
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn More

Innovative Technology

Thermo Fisher Scientific peptones white paper
Sponsored Content
The Value of Peptones for Enhancing Biopharmaceutical Productivity
The Value of Peptones for Enhancing Biopharmaceutical Productivity

Jan 27, 2025

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe